OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NYSE: DELL 21.57%
Why Dell Stock Surged Today
NYSE: ACXIF 31.15%
NYSE: NGNE 31.15%
NYSE: DLLL 31.15%
NYSE: BATL 31.15%
NYSE: EDSA 31.15%
